During this segment, the panelists discuss the various roles that specialty pharmacies perform to assist patients with systemic lupus erythematosus (SLE) and hemophilia.
Hugh Fatodu, RPh, MBA, explains that in SLE, where the disease presents in many different ways and affects many different organ systems, specialty pharmacies coordinate the massive flow of information between different healthcare specialties.
Patrick F. Fogarty, MD, recognizes programs organized by hemophilia treatment centers that provide cost saving incentives and enhance patient care.
However, Maria Lopes, MD, MS, shares her concern about the expensive costs of investigational drugs and the lack of coverage to patients who may require necessary treatment with these products. Dr Lopes suggests that in order to ensure that all treatment options are considered appropriately, there is a need for dynamic conversation between key opinion leaders to discuss missed opportunities within the medical field.
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More